About

Visa agrees to buy BioCatch for $2.4 billion in cash

Published
Score
16

Why it matters

Visa has agreed to acquire BioCatch, an Israeli fraud-detection company, for $2.4 billion in cash. BioCatch operates a behavioral-analytics platform that uses artificial intelligence and machine learning to identify scams, account takeovers, money mule schemes, and application fraud in real time by analyzing user behavior and device signals across digital banking sessions. The company serves more than 350 banking clients globally and processes signals from thousands of devices and users. Permira and other shareholders are selling the business, which is led by CEO Gadi Mazor.

The transaction requires regulatory approval and is expected to close by the end of Visa's fiscal second quarter in 2027. The specific terms of integration into Visa's broader fraud and risk management operations have not been detailed.

For financial institutions, this deal signals Visa's strategic commitment to embedding fraud prevention deeper into payment infrastructure as AI-driven scams accelerate. Banks relying on legacy fraud systems should assess whether their current detection capabilities meet emerging threats. Institutions already using BioCatch should monitor how Visa integrates the platform with its existing risk services and whether pricing or service terms change post-acquisition.

Sources

mail Subscribe to M & A email updates

Primary sources. No fluff. Straight to your inbox.

Related

View all M & A

Also on LawSnap